Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Amendment of Drug Administration Law and Draft Vaccine Management... 4/22/2019
China to Amend Healthcare Laws Relating to Physicians 4/22/2019
NMPA Solicits Comments on Draft Announcement for Nature Determina... 4/19/2019
Recent Executive Moves 4/19/2019
I-Mab Signs Agreement with Roche for Clinical Research of TJD5 in... 4/18/2019
HitGen Achieves Milestone from DEL Discovery Alliance with Merck ... 4/18/2019
U.S. Senators Propose Bill to Sanction Chinese Pharmchem Cos over... 4/18/2019
Lonza's Specialty API Business Disrupted by Chinese Plant Explosi... 4/18/2019
Rexahn Pharma, BioSense Global Announce License Agreement for Ant... 4/17/2019
CASI In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 mA... 4/17/2019
GSK CEO Pledges to Learn from Mistakes in the Booming Chinese Vac... 4/17/2019
More>>
 
Feature Articles
 
Rare Diseases in China, Their High Treatment Costs, and the Peopl... 4/18/2019
Pharmaceutical Antitrust in China 4/17/2019
Bayer Pharma Hit with China-attributed Malware 4/16/2019
'Reverse Patent Trolls' Plague Big Pharma in China 4/16/2019
FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 ... 4/3/2019
PharmExec: Use of External Innovation in China 4/3/2019
MNCs Need Perseverance as China Ratchets Up Cost Containment amid... 4/1/2019
3 Key Takeaways From BeiGene's CEO 3/26/2019
Why China's New Legal Framework Will Be A Magnet for Global Pharm... 3/21/2019
MAH Program A Shot in the Arm for Chinese Pharmaceutical Industry... 3/19/2019
5 Key Elements of Chinese Biopharma's "Cambrian Explosion" 3/17/2019
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links